hypertrophic cardiomyopathy - search results
If you're not happy with the results, please do another search
EHRA 2023: Extended ECG monitoring detects more arrhythmias in hypertrophic cardiomyopathy
Thirty-day electrocardiogram (ECG) monitoring in patients with hypertrophic cardiomyopathy (HCM) detects more arrhythmias than the standard 24 to 48 hours, according to late breaking...
Clinical trial set to use biometrics data platform to study hypertrophic cardiomyopathy
UC San Francisco (UCSF) is conducting a six-month clinical trial on hypertrophic cardiomyopathy (HCM) using Vivalink's Biometrics Data Platform. The study, consisting of 70...
Disparities found in management of hospitalised patients with hypertrophic cardiomyopathy
New research suggests that implantable cardioverter defibrillators (ICDs) are not used as frequently for females and patients of colour, despite the increased use of ICDs...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...
Hypertrophic cardiomyopathy patients at risk of sudden cardiac death may be eligible for S-ICD
Patients with hypertrophic cardiomyopathy at risk of sudden cardiac death and without pacing indication may be eligible for Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) implantation, according to results of a single-centre study.
New drug candidate may prevent and reverse hypertrophic cardiomyopathy in mouse models
MYK-461, a drug candidate from MyoKardia, may prevent and reverse development of hypertrophic cardiomyopathy in multiple genetic mouse models, according to a study published in Science.
Sudden death predictor identifies ICD candidates in new ESC Guidelines
A new sudden death predictor for patients with hypertrophic cardiomyopathy identifies candidates for implantable cardioverter defibrillators (ICDs) in ESC Guidelines published recently. They were presented at the European Society of Cardiology (ESC) Congress by Task Force chairperson Perry Elliott (The Heart Hospital, London, UK).
US FDA grants de novo approval for AI-based HCM detection algorithm
Viz.ai has received a de novo approval by the US Food and Drug Administration (FDA) for its Viz HCM module, a hypertrophic cardiomyopathy (HCM)...
AI model can allow for interpretation of ECGs as language
Researchers have developed an artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
This approach can enhance...
New guidance issued on screening for sudden cardiac death in athletes
Recommendations on how to use gene testing to prevent sudden cardiac death in athletes and enable safe exercise have been published in the European...
Research highlights AF risk factors for HCM patients
The authors of research published in JACC: Clinical Electrophysiology claim that their findings will help physicians to identify, treat and prevent atrial fibrillation (AF)...
Mavacamten granted US FDA new drug application
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for mavacamten, an investigational,...
ACC.21 late-breaking clinical trial programme announced
The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials to be presented at its 70th annual scientific session...
Digital platform takes 2020 ESC Congress to a wider audience
Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking place from 29 August–1 September, the event’s scientific chair Marco Roffi (University Hospitals...
Research demonstrates the promise of algorithm-based ambulatory cardiac monitoring
iRhythm Technologies has announced the publication of a new study in Nature Medicine showing expert-level detection of cardiac arrhythmias using a new deep learning,...
Familial screening after sudden death in young patients is effective even without autopsy
Pauline Quenin (I’institut du thorax, INSERM, CNRS, UNIV Nantes, CHU Nantes, Nantes, France) and others report in Circulation Arrhythmia and Electrophysiology that a quarter...
Cardiac sympathetic denervation helps to reduce sustained ventricular tachycardia and ICD shocks
By Angela Gonzalez
A retrospective study, including the largest series of patients with refractory ventricular tachycardia undergoing cardiac sympathetic denervation for structural heart disease, has...
Research argues requirements for AEDs in US schools need improvement
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed in schools, yet only 17 out of 50 US...
First guideline for evaluating and managing syncope released in USA
The American College of Cardiology (ACC), the American Heart Association (AHA) and the Heart Rhythm Society (HRS) have recently released the first US guideline...
Relevance of imaging for ventricular tachycardia ablation
Cardiac imaging has emerged as an integral part of mapping and ablation in a variety of complex arrhythmias. Advances in imaging techniques, especially the...
New recommendations green-light some athletes with heart disease to compete in competitive sport
The recommendations from the American Heart Association and the American College of Cardiology may permit participation in competitive sports for some athletes with long QT syndrome
Study highlights gender-related differences in athletes’ hearts
The study about gender differences in athletes' hearts highlights the importance of understanding how women's hearts work, and that what looks normal in men could reveal problems in women.
Hung-Fat Tse
While Hung-Fat Tse's initial research interests focused on device therapy for cardiac arrhythmias, he has dedicated his career to the development of cardiovascular regenerative medicine.
AHA and ACC release scientific statement on congenital and genetic heart disease screening
The American Heart Association (AHA) and American College of Cardiology (ACA) have released a statement including 14 key elements that can be used as a checklist for screening young people age 12-25 for congenital and genetic heart disease.
Coil embolisation now used to treat ventricular tachycardias
Physicians in the USA are using, for the first time, coil embolisation to treat severe ventricular tachycardias. The intervention is normally employed for treating brain aneurysms. Cardiac Rhythm News spoke to Kalyanam Shivkumar, co-author of the report in more detail about the technique, its benefits and most suitable patients for this procedure.
Pregnancy in women with implantable cardioverter defibrillators associated with a good outcome but complications...
Pia Schuler, The Grown Up Congenital Heart Disease Unit, The Heart Hospital, University College London Hospitals, London, UK, and others reported that there is little data for the effect of pregnancy on women with ICDs. Thus, they reviewed the outcome of pregnant women with an ICD at their centre.
TomTec introduces 2D Cardiac Performance Analysis MR software solution for cardiac magnetic resonance imaging
2D Cardiac Performance Analysis MR analyses myocardial function and deformation in standard magnetic resonance cine sequences and does not require specific acquisition modes like tagged imaging.
New study suggests that electrocardiograms may not be the right tool for preparticipation screening...
There is ongoing debate as to whether or not young athletes should undergo preparticipation screening, using an electrocardiogram (ECG), to reduce the risk of sudden cardiac death. A new study indicates that preparticipation ECGs are difficult to interpret and as a result, the wrong guidance may be given.
Should we have preparticipation ECG screening in young athletes?
Will Nicolson, University of Leicester, UK, comments on the findings from the two new studies on electrocardiograms for preparticipation screening in young athletes published in the Journal of Pediatrics and Circulation. He said that according to the results "it is possible that preparticipation ECG screening would cause more long-term deaths through inactivity than it saved through appropriate diagnosis in the short term."
Entirely subcutaneous ICD treats ventricular arrhythmias
Gust H Bardy believes S-ICDs to prove a "viable alternative" to the transvenous system.
Virtual ACC: LivaNova highlights Vitaria data
Data on the use of LivaNova’s implantable neuromodulation technology, Vitaria, for heart failure patients has been shared at the American College of Cardiology/World Congress...
Virtual ACC: Ethanol infusion in vein of Marshall improves catheter ablation outcomes
The infusion of ethanol via the vein of Marshall (VOM), coupled with catheter ablation, leads to improved outcomes for patients with persistent atrial ablation, according to the findings of a study presented by...
